Evaluation of Antibiotic Administration Following Tooth Extraction

Launched by CHITTAGONG MEDICAL COLLEGE · Jul 13, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating whether giving antibiotics after a tooth extraction can help patients heal better and reduce the risk of infections. It will involve 152 patients aged 18 to 50 who are scheduled to have a tooth extracted. Participants will be randomly divided into two groups: one group will receive antibiotics after their procedure, while the other group will not. The study will look at how well each group heals, how much pain they experience, and if there are any side effects from the antibiotics.

To be eligible for this trial, participants need to be healthy adults who are going to have a tooth extracted and can provide written consent. However, people with certain health conditions, such as severe infections or those who are pregnant, will not be able to participate. The trial will ensure participant safety and ethical standards by getting consent and monitoring health closely throughout the study. This research may help dentists understand the best practices for post-extraction care in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patient indicated extraction of teeth
• • 2. Provide informed written consent
• • 3. Patients aged between 18 to 50 years
• Exclusion Criteria:
• • 1. The tooth with abscess, infected cyst and tumors that require extensive surgery including impacted teeth
• • 2. Patients who have taken antibiotics before 5 days for any reason will be excluded
• • 3. Patients who are medically compromised such as DM, Congenital cyanotic heart disease, chronic kidney disease (CKD), Patients with chemotherapy or radiotherapy, Chronic Liver Disease (CLD), etc.
• • 4. Female patients who are pregnant or lactating
• • 5. Those women during the menstruation period (disturbed fibrinolytic activity),
• • 6. Participants who are known hypersensitive to the given drugs used in this study
• • 7. Participants who have known resistance to intervention drugs